Search research articles
Contact Us
Filters
Showing results (51-60 of 69) with videos related to
Page
of 7
Sort By:
American Journal of Respiratory and Critical Care Medicine
|
September 24, 2020
Reply to Lipworth <i>et al.</i>: Don't Forget about Facilitatory Effects of Corticosteroids on β<sub>2</sub>-Adrenoceptors in Acute Asthma
Angela M Moran, Sanjay Ramakrishnan, Catherine A Borg, et al.
ERJ Open Research
|
February 26, 2025
The carbon footprint of diagnostic delays in asthma
Lauranne Pouliot, Laurence Désy, Sarah-Ève Lemieux, et al.
American Journal of Respiratory and Critical Care Medicine
|
June 26, 2020
Blood Eosinophil Depletion with Mepolizumab, Benralizumab, and Prednisolone in Eosinophilic Asthma
Angela M Moran, Sanjay Ramakrishnan, Catherine A Borg, et al.
American Journal of Respiratory and Critical Care Medicine
|
August 18, 2025
Normal FEV<sub>1</sub> without Reversibility in Asthma Trials - A Placebo Patient-Level Meta-Analysis
Simon Couillard, Samuel Mailhot-Larouche, Fleur L Meulmeester, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
September 10, 2023
Consensus of an American College of Allergy, Asthma, and Immunology, American Academy of Allergy, Asthma, and Immunology, and American Thoracic Society workgroup on definition of clinical remission in asthma on treatment
Michael Blaiss, John Oppenheimer, Mark Corbett, et al.
American Journal of Respiratory and Critical Care Medicine
|
June 15, 2021
Fractional Exhaled Nitric Oxide Nonsuppression Identifies Corticosteroid-Resistant Type 2 Signaling in Severe Asthma
Simon Couillard, Rahul Shrimanker, Rekha Chaudhuri, et al.
The European Respiratory Journal
|
February 13, 2025
Phenotyping the responses to systemic corticosteroids in the management of asthma attacks (PRISMA)
Carlos Celis-Preciado, Simon Leclerc, Martine Duval, et al.
Thorax
|
July 8, 2022
Longitudinal changes in sputum and blood inflammatory mediators during FeNO suppression testing
Simon Couillard, Rahul Shrimanker, Samuel Lemaire-Paquette, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
April 12, 2026
Protocol for a multinational, investigator-initiated, parallel group, randomised, double-blind, placebo-controlled phase 3b superiority trial assessing the effect of dupilumab on inducing clinical remission outcomes in at-risk type-2 inflammatory asthma (HOTHOT)
Simon Couillard, Nayia Petousi, Sanjay Ramakrishnan, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
January 27, 2024
Phenotyping of Severe Asthma in the Era of Broad-Acting Anti-Asthma Biologics
Arnaud Bourdin, Guy Brusselle, Simon Couillard, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 69) with videos related to
Sort By:
Page
of 7
American Journal of Respiratory and Critical Care Medicine
|
September 24, 2020
Reply to Lipworth <i>et al.</i>: Don't Forget about Facilitatory Effects of Corticosteroids on β<sub>2</sub>-Adrenoceptors in Acute Asthma
Angela M Moran, Sanjay Ramakrishnan, Catherine A Borg, et al.
ERJ Open Research
|
February 26, 2025
The carbon footprint of diagnostic delays in asthma
Lauranne Pouliot, Laurence Désy, Sarah-Ève Lemieux, et al.
American Journal of Respiratory and Critical Care Medicine
|
June 26, 2020
Blood Eosinophil Depletion with Mepolizumab, Benralizumab, and Prednisolone in Eosinophilic Asthma
Angela M Moran, Sanjay Ramakrishnan, Catherine A Borg, et al.
American Journal of Respiratory and Critical Care Medicine
|
August 18, 2025
Normal FEV<sub>1</sub> without Reversibility in Asthma Trials - A Placebo Patient-Level Meta-Analysis
Simon Couillard, Samuel Mailhot-Larouche, Fleur L Meulmeester, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
September 10, 2023
Consensus of an American College of Allergy, Asthma, and Immunology, American Academy of Allergy, Asthma, and Immunology, and American Thoracic Society workgroup on definition of clinical remission in asthma on treatment
Michael Blaiss, John Oppenheimer, Mark Corbett, et al.
American Journal of Respiratory and Critical Care Medicine
|
June 15, 2021
Fractional Exhaled Nitric Oxide Nonsuppression Identifies Corticosteroid-Resistant Type 2 Signaling in Severe Asthma
Simon Couillard, Rahul Shrimanker, Rekha Chaudhuri, et al.
The European Respiratory Journal
|
February 13, 2025
Phenotyping the responses to systemic corticosteroids in the management of asthma attacks (PRISMA)
Carlos Celis-Preciado, Simon Leclerc, Martine Duval, et al.
Thorax
|
July 8, 2022
Longitudinal changes in sputum and blood inflammatory mediators during FeNO suppression testing
Simon Couillard, Rahul Shrimanker, Samuel Lemaire-Paquette, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
April 12, 2026
Protocol for a multinational, investigator-initiated, parallel group, randomised, double-blind, placebo-controlled phase 3b superiority trial assessing the effect of dupilumab on inducing clinical remission outcomes in at-risk type-2 inflammatory asthma (HOTHOT)
Simon Couillard, Nayia Petousi, Sanjay Ramakrishnan, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
January 27, 2024
Phenotyping of Severe Asthma in the Era of Broad-Acting Anti-Asthma Biologics
Arnaud Bourdin, Guy Brusselle, Simon Couillard, et al.
Page
of 7